Word

JIXING

Status

Pending

Status Code

731

Status Date

Tuesday, March 19, 2024

Serial Number

90901227

Mark Type

4000

Filing Date

Wednesday, August 25, 2021

Published for Opposition

Tuesday, January 24, 2023

Trademark Owner History

Ji Xing Pharmaceuticals (Shanghai) Co.,Ltd. - Owner At Publication

Classifications

5 Pharmaceutical products and preparations for the treatment of cardiovascular diseases and disorders, ophthalmic diseases and disorders, respiratory diseases and disorders, hyperlipidemia, hypertension, pulmonary hypertension, cancer, diabetes, infectious diseases, hypercholesterolemia, allergies, inflammation, and pain; biological products and preparations for the treatment of cardiovascular diseases and disorders, ophthalmic diseases and disorders, respiratory diseases and disorders, hyperlipidemia, hypertension, pulmonary hypertension, cancer, diabetes, infectious diseases, hypercholesterolemia, allergies, inflammation, and pain for medical use

42 Scientific research and development; research and development in the pharmaceutical and biotechnology fields; research and development of technology in the fields of disease treatment and gene therapy; technological assessment, research, and development of medical devices, pharmaceutical products, gene therapies, and treatment modalities for a range of diseases

Trademark Events

Mar 20, 2024

Notice Of Approval Of Extension Request E-Mailed

Mar 19, 2024

Sou Extension 2 Granted

Mar 19, 2024

Sou Extension 2 Filed

Mar 19, 2024

Sou Teas Extension Received

Sep 23, 2023

Notice Of Approval Of Extension Request E-Mailed

Sep 21, 2023

Sou Extension 1 Granted

Sep 21, 2023

Sou Extension 1 Filed

Sep 21, 2023

Sou Teas Extension Received

Mar 21, 2023

Noa E-Mailed - Sou Required From Applicant

Jan 24, 2023

Official Gazette Publication Confirmation E-Mailed

Jan 24, 2023

Published For Opposition

Jan 4, 2023

Notification Of Notice Of Publication E-Mailed

Dec 22, 2022

Approved For Pub - Principal Register

Dec 3, 2022

Notification Of Final Refusal Emailed

Dec 3, 2022

Final Refusal E-Mailed

Dec 3, 2022

Final Refusal Written

Dec 1, 2022

Teas/Email Correspondence Entered

Nov 30, 2022

Correspondence Received In Law Office

Nov 30, 2022

Teas Response To Office Action Received

May 31, 2022

Notification Of Non-Final Action E-Mailed

May 31, 2022

Non-Final Action E-Mailed

May 31, 2022

Non-Final Action Written

May 30, 2022

Assigned To Examiner

Oct 11, 2021

New Application Office Supplied Data Entered

Aug 28, 2021

New Application Entered